Search filters

List of works by Lambert Assoumou

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

scientific article published on 25 October 2014

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

scientific article published on 2 May 2017

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

scientific article published in January 2011

Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.

scientific article published on 17 February 2015

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, ra

scientific article

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

article

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)

article

HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART

article

HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide

scientific article published on 13 June 2008

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

scientific article published in February 2010

Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial

scientific article published on 27 January 2019

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients

scientific article

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study

scientific article published on 16 February 2014

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

scientific article

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibit

scientific article published in July 2009

Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study: Figure 1

scientific article published on 26 April 2015

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study

scientific article published on 12 February 2013

Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study

scientific article published in September 2007

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

scientific article published on 17 July 2015

Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery

scientific article published on 29 March 2019

Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia

scientific article published on April 2015

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

scientific article published on January 2016

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

scientific article

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

scientific article

Paulina is supported by:

About Paulina

Help